1. Catalog
  2. Is there a bright line? Exploring peri-fertilizati ...
Is there a bright line? Exploring peri-fertilization knowns and unknowns
Researchers, clinicians, legal, and ethics experts consider peri-fertilization knowns and unknowns related to emergency contraception, missed period pills, ulipristal acetate in medication abortion regimens, and treatment of pregnancy of unknown location, and how they expand or restrict access to contraception and abortion, abortion stigma, and patient-centered decision making.
Accreditation


Physicians: The Society of Family Planning is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The Society of Family Planning designates this enduring activity for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses: For the purpose of recertification, the American Nurses Credentialing Center (ANCC) accepts AMA PRA Category 1 Credit(s)™ issued by organizations accredited by the ACCME.

Physician Assistants: Physician Assistants may claim a maximum of 1.25 Category 1 credits for completing this activity. The National Commission on Certification of Physician Assistants (NCCPA) accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.

Other Healthcare Professionals: All non-physician healthcare professionals who complete this accredited activity will receive a certificate documenting completion of the course and associated credit. Many societies and credentialing bodies accept accredited CME activities as long as the topic is relevant to the applicant’s field or discipline.

If you have questions whether this activity meets the education or licensure requirements for your discipline, please consult your licensing or certifying board. You may also contact our Continuing Education team at CME@SocietyFP.org for support.

Learning objectives
At the conclusion of this activity, participants will be able to:  
1. Describe the current evidence base regarding the mechanism of action for menstrual regulation, contraception, contragestion, and early abortion care.
2. Name two examples of how the presence or absence of a “bright line” in defining contraception and abortion impacts clinical practice, patient counseling, and access to contraception and abortion care.
3. Name two examples of the ethical, legal, and policy considerations related to peri-fertilization interventions, including impacts on insurance coverage, reporting requirements, and abortion stigma.
4. Identify one research gap or research priority related to liminal reproductive healthcare options.
5. Describe one communication strategy to advance access to liminal reproductive healthcare options within your institutional, local, or regional contexts.  
Course information

Instructions for claiming CE credit
To earn continuing education credit and a certificate for completing this course, you must complete the post-webinar evaluation.

Release and expiration dates
CME activity released: 
CME activity expires: 

Acknowledgement of commercial support
No commercial support was received in the production of this activity.

Disclosure summary
The Society of Family Planning asks all individuals involved in the development and presentation of Accredited Continuing Education activities to disclose all financial relationships with ineligible companies. This information is disclosed to activity participants prior to the start of the educational activity. The Society has procedures to mitigate all relevant financial relationships with ineligible companies. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed. 

Name Disclosure(s)
 Kelly Cleland, MPA, MPH  Kelly has no financial relationships to disclose.
 Kim Mutcherson, JD  Kim has no financial relationships to disclose. 
 Siri Nippita, MD, MS  Siri has no financial relationships to disclose. 
 Cari Sietstra, JD  Cari has no financial relationships to disclose. 
 Dana Singiser, JD  Dana is a consultant to Mayne Pharma.
 David Turok, MD, MPH   David is a consultant to Sebela Pharmaceuticals and an advisor to 3Daughters and Anther Therapeutics. 
 Katie Watson, JD  Katie has no financial relationships to disclose.
Summary
Availability:
On-Demand
Cost:
FREE
Credit Offered:
1.25 CME Credits
Recommended
Powered By